SCHEMBL19814952

SCHEMBL19814952

O=C(O)C1CCCC2(CCCN2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.41
▸ SLC6A1 P30531 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ SLC6A11 P48066 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ SLC6A13 Q9NSD5 1/20 0.41
▸ GRM2 Q14416 2/20 0.39
▸ GRM3 Q14832 2/20 0.39
▸ GRM4 Q14833 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ GRM8 O00222 1/20 0.39
▸ GRM6 O15303 1/20 0.39
▸ GRM5 P41594 1/20 0.39
▸ MTOR P42345 1/20 0.39
▸ GRM1 Q13255 1/20 0.39
▸ PLCB1 Q9NQ66 1/20 0.39
▸ GABRP O00591 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19815193 0.94 TSHR (0.42) TSHRSLC6A1LMNASLC6A11SMN1; SMN2
SCHEMBL10970110 0.93 TSHR (0.43) TSHRSLC6A1LMNASLC6A11SMN1; SMN2
SCHEMBL1665499 0.93 TSHR (0.43) TSHRSLC6A1LMNASLC6A11SMN1; SMN2
SCHEMBL9715688 0.93 TSHR (0.43) TSHRSLC6A1LMNASLC6A11SMN1; SMN2
SCHEMBL29585583 0.87 TSHR (0.43) TSHRSLC6A1LMNASLC6A11SMN1; SMN2
SCHEMBL30104750 0.86 CYP2C19 (0.44) TSHRSLC6A1LMNASLC6A11SMN1; SMN2
SCHEMBL14486454 0.85 TSHR (0.41) TSHRSLC6A1LMNASLC6A11SMN1; SMN2
SCHEMBL29373164 0.84 KDM4E (0.43) ARG1KMT2A
SCHEMBL15618894 0.82 TSHR (0.47) TSHRSLC6A1LMNASLC6A11SMN1; SMN2
SCHEMBL29584487 0.82 TSHR (0.46) TSHRSLC6A1LMNASLC6A11SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3890829-A1 PHARMACEUTICAL COMPOUNDS AND THEIR USE AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 19 (USP19) Almac Discovery Limited (GB) 2021-10-13 — — EP disclosed
EP-3746432-A1 4-HYDROXYPIPERIDINE DERIVATIVES AND THEIR USE AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 19 (USP19) Almac Discovery Limited (GB) 2020-12-09 — — EP disclosed
WO-2020115501-A1 PHARMACEUTICAL COMPOUNDS AND THEIR USE AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 19 (USP19) ALMAC DISCOVERY LIMITED (GB) 2020-06-11 — — WO disclosed
WO-2019150119-A1 4-HYDROXYPIPERIDINE DERIVATIVES AND THEIR USE AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 19 (USP19) ALMAC DISCOVERY LIMITED (GB) 2019-08-08 — — WO disclosed
EP-3490982-A1 PHARMACEUTICAL COMPOUNDS Almac Discovery Limited (GB) 2019-06-05 — — EP disclosed
WO-2018020242-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2018-02-01 — — WO disclosed
Send feedback